PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF INTERLEUKINS AND THERAPEUTIC APPLICATIONS THEREOF

PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF INTERLEUKINS AND THERAPEUTIC APPLICATIONS THEREOF

The invention relates to novel pharmaceutical formulations based on fluids and stable aqueous colloidal suspensions for the sustained release of an interleukin IL- (and one or more other optional active principles), and to the applications, particularly the therapeutic applications, of said formulat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MEYRUEIX REMI, SOULA OLIVIER, BIGNON SOPHIE
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MEYRUEIX REMI
SOULA OLIVIER
BIGNON SOPHIE
description The invention relates to novel pharmaceutical formulations based on fluids and stable aqueous colloidal suspensions for the sustained release of an interleukin IL- (and one or more other optional active principles), and to the applications, particularly the therapeutic applications, of said formulations. According to the invention, the formulation is a low-viscosity aqueous colloidal suspension of submicronic particles of water-soluble, biodegradable polymer PO bearing hydrophobic groups (GH). The aforementioned particles are noncovalently associated with at least one interleukin (and one or more other optional active principles) and form a gelled deposit on the injection site, said gelling being caused by a protein present in the physiological medium.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20060134936A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20060134936A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20060134936A3</originalsourceid><addsrcrecordid>eNqNjL0KwjAURrs4iPoOF5yFaqTQ8ZLekNA0CfmZS5E4iGihvj-26gM4fRy-w1kXNyfRd8gpRcVRg7C-SxqjsiYsAFEShBQiKkMNeNKEgcAKUCaS15RaNZtomsX06D4hQOf03PtmloOs2Bar63Cf8u63m2IvKHJ5yOOzz9M4XPIjv_rWn8qyKo_sXLMK2X_WG64CN4c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF INTERLEUKINS AND THERAPEUTIC APPLICATIONS THEREOF</title><source>esp@cenet</source><creator>MEYRUEIX REMI ; SOULA OLIVIER ; BIGNON SOPHIE</creator><creatorcontrib>MEYRUEIX REMI ; SOULA OLIVIER ; BIGNON SOPHIE</creatorcontrib><description>The invention relates to novel pharmaceutical formulations based on fluids and stable aqueous colloidal suspensions for the sustained release of an interleukin IL- (and one or more other optional active principles), and to the applications, particularly the therapeutic applications, of said formulations. According to the invention, the formulation is a low-viscosity aqueous colloidal suspension of submicronic particles of water-soluble, biodegradable polymer PO bearing hydrophobic groups (GH). The aforementioned particles are noncovalently associated with at least one interleukin (and one or more other optional active principles) and form a gelled deposit on the injection site, said gelling being caused by a protein present in the physiological medium.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061228&amp;DB=EPODOC&amp;CC=KR&amp;NR=20060134936A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061228&amp;DB=EPODOC&amp;CC=KR&amp;NR=20060134936A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MEYRUEIX REMI</creatorcontrib><creatorcontrib>SOULA OLIVIER</creatorcontrib><creatorcontrib>BIGNON SOPHIE</creatorcontrib><title>PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF INTERLEUKINS AND THERAPEUTIC APPLICATIONS THEREOF</title><description>The invention relates to novel pharmaceutical formulations based on fluids and stable aqueous colloidal suspensions for the sustained release of an interleukin IL- (and one or more other optional active principles), and to the applications, particularly the therapeutic applications, of said formulations. According to the invention, the formulation is a low-viscosity aqueous colloidal suspension of submicronic particles of water-soluble, biodegradable polymer PO bearing hydrophobic groups (GH). The aforementioned particles are noncovalently associated with at least one interleukin (and one or more other optional active principles) and form a gelled deposit on the injection site, said gelling being caused by a protein present in the physiological medium.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjL0KwjAURrs4iPoOF5yFaqTQ8ZLekNA0CfmZS5E4iGihvj-26gM4fRy-w1kXNyfRd8gpRcVRg7C-SxqjsiYsAFEShBQiKkMNeNKEgcAKUCaS15RaNZtomsX06D4hQOf03PtmloOs2Bar63Cf8u63m2IvKHJ5yOOzz9M4XPIjv_rWn8qyKo_sXLMK2X_WG64CN4c</recordid><startdate>20061228</startdate><enddate>20061228</enddate><creator>MEYRUEIX REMI</creator><creator>SOULA OLIVIER</creator><creator>BIGNON SOPHIE</creator><scope>EVB</scope></search><sort><creationdate>20061228</creationdate><title>PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF INTERLEUKINS AND THERAPEUTIC APPLICATIONS THEREOF</title><author>MEYRUEIX REMI ; SOULA OLIVIER ; BIGNON SOPHIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20060134936A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MEYRUEIX REMI</creatorcontrib><creatorcontrib>SOULA OLIVIER</creatorcontrib><creatorcontrib>BIGNON SOPHIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MEYRUEIX REMI</au><au>SOULA OLIVIER</au><au>BIGNON SOPHIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF INTERLEUKINS AND THERAPEUTIC APPLICATIONS THEREOF</title><date>2006-12-28</date><risdate>2006</risdate><abstract>The invention relates to novel pharmaceutical formulations based on fluids and stable aqueous colloidal suspensions for the sustained release of an interleukin IL- (and one or more other optional active principles), and to the applications, particularly the therapeutic applications, of said formulations. According to the invention, the formulation is a low-viscosity aqueous colloidal suspension of submicronic particles of water-soluble, biodegradable polymer PO bearing hydrophobic groups (GH). The aforementioned particles are noncovalently associated with at least one interleukin (and one or more other optional active principles) and form a gelled deposit on the injection site, said gelling being caused by a protein present in the physiological medium.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_KR20060134936A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF INTERLEUKINS AND THERAPEUTIC APPLICATIONS THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A50%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MEYRUEIX%20REMI&rft.date=2006-12-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20060134936A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true